Cubist Systematic Strategies, LLC Cytek Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$5.52 - $9.5 $82,772 - $142,452	14,995 New	14,995 $82,000
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $466,461 - $744,459	-55,268 Reduced 61.11%	35,172 $323,000
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $447,378 - $730,733	46,074 Added 103.85%	90,440 $923,000
Q3 2022 Nov 14, 2022	SELL	$10.96 - $15.45 $435,747 - $614,261	-39,758 Reduced 47.26%	44,366 $653,000
Q2 2022 Aug 15, 2022	SELL	$7.41 - $11.56 $1.12 Million - $1.75 Million	-151,509 Reduced 64.3%	84,124 $903,000
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $2.33 Million - $4.06 Million	235,633 New	235,633 $2.54 Million
Q4 2021 Feb 14, 2022	SELL	$16.14 - $25.04 $138,804 - $215,344	-8,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $150,672 - $240,198	8,600 New	8,600 $184,000

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $851M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.